SmartPDT®: Smartphone enabled real-time dosimetry via satellite observation for daylight photodynamic therapy

Luke J. McLellan*, Marco Morelli, Emilio Simeone, Marina Khazova, Sally H. Ibbotson, Ewan Eadie

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Background: Actinic keratosis (AK) affects one quarter of over 60 year olds in Europe with the risk of transforming into invasive squamous cell carcinoma. Daylight photodynamic therapy (dPDT) is an effective and patient preferred treatment that uses sunlight to clear AK. Currently, there is no standardised method for measuring the light received during treatment. 

Methods: SmartPDT® is a smartphone-based application and web-portal, developed by siHealth Ltd, enabling remote delivery of dPDT. It uses satellite imagery and computational algorithms to provide real-time determination of exposure to PpIX-effective solar radiation (“light dose”). The application also provides forecast of expected radiant exposures for 24- and 48-hs prior to the treatment period. Validation of the real-time and forecasted radiant exposure algorithms was performed against direct ground-based measurement under all weather conditions in Chilton, UK. 

Results: Agreement between direct ground measurements and satellite-determined radiant exposure for 2-h treatment was excellent at −0.1 % ± 5.1 % (mean ± standard deviation). There was also excellent agreement between weather forecasted radiant exposure and ground measurement, 1.8 % ± 17.7 % at 24-hs and 1.6 % ± 25.2 % at 48-hs. Relative Root Mean Square of the Error (RMSEr) demonstrated that agreement improved as time to treatment reduced (RMSEr = 22.5 % (48 -hs), 11.2 % (24-hs), 5.2 % (real-time)). 

Conclusion: Agreement between satellite-determined, weather-forecasted and ground-measured radiant exposure was better than any existing published literature for dPDT. The SmartPDT® application and web-portal has excellent potential to assist with remote delivery of dPDT, an important factor in reducing risk in an elderly patient population during the Covid-19 pandemic.

Original languageEnglish
Article number101914
JournalPhotodiagnosis and Photodynamic Therapy
Volume31
Early online date6 Jul 2020
DOIs
Publication statusPublished - Sep 2020

Bibliographical note

Funding Information: L. J. M’s salary is supported by an Innovate UK award and by the Medical Laser Research Fund (registered charity SC037390).

M. M is a board director and CTO of siHealth Ltd. and E. S is founder
and CEO of siHealth Ltd

Open Access: Free to read, but no Open Access licence.

Publisher Copyright: © 2020 Elsevier B.V. All rights reserved.

Citation: McLellan LJ, Morelli M, Simeone E, Khazova M, Ibbotson SH, Eadie E. SmartPDT®: Smartphone enabled real-time dosimetry via satellite observation for daylight photodynamic therapy. Photodiagnosis Photodyn Ther. 2020;31:101914.

DOI: 10.1016/j.pdpdt.2020.101914

Keywords

  • Daylight photodynamic therapy
  • Dosimetry
  • Live dosimetry
  • Photodynamic therapy

Fingerprint

Dive into the research topics of 'SmartPDT®: Smartphone enabled real-time dosimetry via satellite observation for daylight photodynamic therapy'. Together they form a unique fingerprint.

Cite this